| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
|---|---|---|---|---|---|---|
| CP00014521410 |
|
13278-36-9 |
Clofenamicacid - 98% |
0 | C13H10ClNO2 | |
| CP0001452141 |
|
159414-97-8 |
N4-Acetyl-2'-Fluoro-2'-deoxycytidine - 98% |
0 | C11 H14 F N3 O5 | |
| CP0001452140 |
|
74844-91-0 |
N-Boc-trans-4-Hydroxy-L-proline methyl ester - 98% |
0 | C11H19NO5 | |
| CP0001452139 |
|
104162-48-3 |
N-(1-(2,3-dioleyloxy)propyl)-N,N,N-trimethylammonium - ≥90% |
0 | C42H84ClNO2 | |
| CP00014521330 |
|
518048-05-0 |
Raltegravir - 98% |
0 | C20H21FN6O5 | |
| CP0001452133 |
|
845771-78-0 |
Aflibercept - 98% |
0 | — | |
| CP0001452132 |
|
196078-29-2 |
mepolizumab - 98% |
0 | — | |
| CP0001452130 |
|
554-13-2 |
Lithiumcarbonate - 98% |
0 | CLi2O3 | |
| CP0001452110 |
|
59-31-4 |
2-Quinolinol - 98% |
0 | C8H11NO4S | |
| CP00014523 |
|
65963-40-8 |
chlorophyllin copper complex sodium salt - 98% |
0 | a:C34H30CuN4Na2O5;b:C34H28CuN4Na2O6 | |
| CP000145211 |
|
1173-88-2 |
Oxacillin sodium - 98% |
0 | C19H18N3NaO5S | |
| CP00014522 |
![3-[N,N-Bis(hydroxyethyl)amino]-2-hydroxypropanesulphonic acid sodium salt](/image/8987)
|
102783-62-0 |
3-[N,N-Bis(hydroxyethyl)amino]-2-hydroxypropanesulphonic acid sodium salt - 98% |
0 | C7H16NNaO6S | |
| CP000145210 |
|
3775-29-9 |
N/A - 98% |
0 | ||
| CP00014521 |
|
10010-67-0 |
Sodiumhydrogenpiperazine-1,4-diethanesulphonate - 98% |
0 | C8H17N2NaO6S2 | |
| CP00014520 |
|
135-20-6 |
Cupferron - 98% |
0 | C6H9N3O2 | |
| CP0001452 |
|
863971-44-2 |
Sodium tripolyphosphate - 98% |
0 | C36H51N3O7 | |
| CP0001451 |
|
200936-87-4 |
2-aminosulfonyl-N,N-dimethylnicotinamide - 98% |
0 | C11H23NO5 | |
| CP00601 |
|
790702-57-7 |
ML414(NGI-1) - 99% |
0 | C17H22N4O3S2 | |
| CP0001450 |
|
13726-69-7 |
Boc-L-Hydroxyproline - 98% |
0 | C10H17NO5 | |
| CP000144 |
|
1394238-91-5 |
Fmoc-Val-Ala-PAB-OH - 98% |
0 | C30H33N3O5 | |
